Position in BCRX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$219,260
+$12,991 QoQ
Shares Held
21,926
+1.2% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#195
of 316 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PERSONAL CFO SOLUTIONS, LLC holds $2,203,089 across 6 Drug Manufacturers - Specialty & Generic names. BCRX ranks #4 (10.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
32,316 | $1,094,866 | |
| 2 | TAK |
Takeda Pharmaceutical Co Ltd
|
17,738 | $284,340 | |
| 3 | ZTS |
Zoetis Inc.
|
3,816 | $274,217 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
21,926 | $219,260 | |
| 5 | VTRS |
Viatris Inc
|
11,151 | $177,077 | |
| 6 | HLN |
Haleon plc
|
16,434 | $153,329 |
All Filings in BCRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $219,260 | 21,926 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $206,269 | 21,667 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $486,720 | 62,400 | Shares | Defined | 2026-01-22 | |
| 2025-09-30 | $472,006 | 62,188 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $557,204 | 62,188 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $466,410 | 62,188 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $462,600 | 61,516 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $469,155 | 61,731 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $381,497 | 61,731 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $338,993 | 66,731 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $397,154 | 66,303 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $472,632 | 66,756 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $469,962 | 66,756 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $565,085 | 67,756 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $773,637 | 67,390 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $849,114 | 67,390 | Shares | Defined | 2022-11-01 | |
| 2022-06-30 | $709,791 | 67,088 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $1,775,396 | 109,188 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $1,512,253 | 109,188 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,569,031 | 109,188 | Shares | Sole | 2021-11-18 | |
| 2021-06-30 | $1,765,629 | 111,678 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $1,237,465 | 121,678 | Shares | Sole | 2021-04-21 | |
| 2020-12-31 | $783,576 | 105,178 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $313,652 | 91,178 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $393,547 | 82,678 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $174,156 | 87,078 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||